|
?:authorAffiliation
|
-
[\'Center for Vaccine Development and Global Health, University of Maryland School of Medicine, Baltimore, Maryland, USA.\', \'Ifakara Health Institute (IHI), Ifakara, Tanzania.\', \'College of Medicine, King Saud Bin Abdulaziz University for Health Sciences, King Abdullah International Medical Research Center, Riyadh, Kingdom of Saudi Arabia.\', \'CEO, FDA, Cantonments, Accra, Ghana.\', \'Department of International Health, Johns Hopkins University Bloomberg School of Public Health, Baltimore, Maryland, USA.\', \'Medical School, Complutense University, Hospital Clínico San Carlos, Madrid, Spain.\', \'Monash Bioethics Centre, Monash University, Victoria, Australia.\', \'Institut für Tropenmedizin, Universitätsklinikum Tübingen, Germany.\', \'Centre de Recherches Médicales de Lambaréné, Gabon.\', \'Centro para Vacunas en Desarrollo (CVD-Chile), Santiago, Chile.\', \'Vaccine Trial Centre, Faculty of Tropical Medicine, Mahidol University, Bangkok, Thailand.\', \'Department of Pediatrics, University of Pennsylvania, Doylestown, Pennsylvania, USA.\', \'Medical Parasitology Department, Radboud University, Nijmegen, The Netherlands.\', \'Center for Emerging Infectious Diseases, Wuhan Institute of Virology, Wuhan, China.\', \'Centre for Intervention Science in Maternal and Child Health, Department of Global Public Health and Primary Care, University of Bergen, Bergen, and Norwegian Institute of Public Health, Oslo, Norway.\', \'WHO Collaborating Centre for Reference and Research on Influenza and Department of Microbiology and Immunology, University of Melbourne at the Peter Doherty Institute, Melbourne, Australia.\', \'Infectious Diseases Division, University of Rochester Medical Center, Rochester, New York, USA.\', \'Regional Centre for Biotechnology, Haryana (NCR Delhi), India.\', \'Vaccines Priority Area, Wellcome Trust, London, United Kingdom.\', \'Vaccines, Wellcome Trust, London, United Kingdom.\', \'Vaccines Programme, Wellcome Trust, London, United Kingdom.\', \'Global Health Discovery & Translational Sciences, Bill & Melinda Gates Foundation, Seattle, Washington, USA.\', \'Division of Microbiology and Infectious Diseases, National Institute of Allergy and Infectious Diseases, NIH, Bethesda, Maryland, USA.\', \'Office of Vaccines Research and Review, CEBR, FDA, Silver Spring, Maryland, USA.\', \'Chair, WHO R&D Blueprint COVID-19 Vaccines Working Group.\', \'Office of the Executive Director (WHE), WHO Health Emergencies Programme, World Health Organization, Geneva, Switzerland.\']
|
![[This page as RDF]](https://research.tib.eu/covid-19/static/rdf-icon.gif){kind=icon}